EuroPRevent 2012

03 - 05 May 2012, Dublin - Ireland

Session Details

Poster session 2: Poster session 2
Fri 04 May 08:30 - 12:30 Prevention and Epidemiology Poster Session Poster Area - Poster Zone

Abstract Slides/e-posters Video Report

List of Presentations

Related documents
08:30 Group 1.E Prescott (Copenhagen, DK)
08:30P263Reaching low-density lipoprotein cholesterol target levels among high risk dyslipidemic individuals in the Levant region (Jordan and Lebanon)A Hammoudeh (Amman, JO)
08:30P264Treatment pattern changes in high risk patients on statin monotherapy in a managed care settingR Simpson (Chapel Hill, US)
08:30P265Residual lipoprotein abnormalities in statin treated patients: results from the Israeli DYSISd Gavish (Holon, IL)
08:30P266Low HDL and inadequate primary prevention in Offspring of Patients with Premature Coronary Heart Disease in Banja Luka Region/ Republic of Srpska/Bosnia and HerzegovinaD Vulic (Banja Luka, BA)
08:30P267Relation of changes in total and ectopic fat to other cardiovascular risk factors in response to the MyAction vascular prevention programme 
08:30P268Achieving optimal LDL control in a large community based group practice: lipid optimization tool (LOT) audit 2011 at the Ottawa Cardiovascular Centre (OCC)J Niznick (Ottawa, CA)
08:30P269Lp(a) is an independent risk factor for coronary heart disease in men and women: a matched pair analysis in 32.000 patientsK-P Mellwig (Bad Oeynhausen, DE)
08:30P270Decreasing low-density lipoprotein cholesterol in relation to risk of cardiovascular and cerebrovascular events among people with type 2 diabetesJ Reckless (Frome, GB)
08:30P271The effectiveness of primary prevention lags behind secondary prevention management of hyperlipidemia in a community based population at heightened cardiovascular risk. Data from the STOP HF study.CM Conlon (Dublin, IE)
08:30 Group 2.S Sans Menendez (Barcelona, ES)
08:30P272Serum triglyceride levels in patients attending a community based cardiovascular disease prevention programme in the West of IrelandG Flaherty (Co, Galway, IE)
08:30P273Is a lifestyle-based cardiovascular disease prevention programme effective in increasing HDL-cholesterol levels in patients at increased cardiovascular disease risk?G Flaherty (Co, Galway, IE)
08:30P274Lipids targets achievement in EUROASPIRE III ROMANIA FOLLOW-UP: from guidelines to clinical practiceD Gaita (Timisoara, RO)
08:30P275Triglycerides as marker of unfavourable lifestyleA Kalvelis (Riga, LV)
08:30P276Association of severe hypertriglyceridemia and genetic lipoproteinlipase (lpl) mutation and cardio- or cerebrovascular diseaseU Kassner (Berlin, DE)
08:30P277The effect of statins on myocardial infarct extensionV H Pereira (Barcelos, PT)
08:30P278How do European countries measure up? Quantifying tobacco control policy implementation over time 1970 - 2010L M Currie (Dublin 2, IE)
08:30P279Socio-demographic predictors of effective smoking cessation in a group interventionK Doherty (Dublin 4, IE)
08:30P280An analysis of knowledge, attitudes and behaviours related to a progressive campus smoking ban in a large general hospital in the Republic of IrelandI Gilroy (Dublin 4, IE)
08:30P281Predictors of smoking cessation after percutaneous coronary interventionM Licina (Belgrade, RS)
08:30 Group 3.D Vanuzzo (Udine, IT)
08:30P282Intervention strategies for smoking cessation in primary health care in Russia: opportunities and challengesM H Gambaryan (Moscow, RU)
08:30P283Dark chocolate inhibits platelet isoprostanes via nox2 down-regulation in smokersP Pignatelli (Rome, IT)
08:30P284Longitudinal trends in cigarette smoking in the Czech population. The Czech MONICA and post-MONICA studiesR Cifkova (Prague, CZ)
08:30P285The peculiarities of smokers' behaviour among the medicine studentsI Osipova (Barnaul, RU)
08:30P286Effects of nicotine and the smoking cessation aid varenicline on the expression of the acetylcholine receptor alpha4beta2 in-vivoC Both (Duesseldorf, DE)
08:30P287Use of Swedish moist snuff and myocardial infarction: a case-control study of 726 patients and 726 control subjects matched for sex and ageG Nilsson (Vasteras, SE)
08:30P288Real world evaluation of varenicline therapy within a secondary care smoking cessation programmeA J Howe (Belfast, GB)
08:30P289Is it possible a unique prevention for cardiovascular diseases and cancer? Preliminary data from an Italian studyL Palmieri (Rome, IT)
08:30P290Smokers can lose weight when they quit smokingC Pisinger (Glostrup, DK)
08:30P291Acute smoking inhalation impairs left ventricular relaxation in healthy young individuals: a two-dimensional speckle-tracking echocardiography study.K Farsalinos (Lamia, GR)
08:30 Group 4.J Perk (Kalmar, SE)
08:30P292Smoking is risk factor of perioperative cardiovascular events in women undergoing abdominal surgerySY Chu (Beijing, CN)
08:30P293EUROACTION preventive cardiology programme plus intensive smoking cessation with varenicline: Changes in lipid metabolismC S Jennings (London, GB)
08:30P294Family history and coronary disease risk. Interaction with smokingB Silva (Funchal, PT)
08:30P295Understanding smoking prevalence trends in Ireland 2004 - 2011L M Currie (Dublin 2, IE)
08:30P296The nicotine-induced alterations of blood pressure: the impact on the diurnal blood pressure profile E V Pello (Novosibirsk, RU)
08:30P297Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction. 
08:30P298Predictive value of mixed anxiety-depressive symptoms in patients with arterial hypertension and coronary heart diseaseN Pogosova (Moscow, RU)
08:30P299Prognosis in post-MI patients with depressionN Pogosova (Moscow, RU)
08:30P300The association between depressive symptoms and diabetes in Polish adult populationJ Piwonski (Warsaw, PL)
08:30P301In-hospital and long-term prognostic differences between elderly and non-elderly patients admitted for a non-st segment elevation acute coronary syndromeM A Ramirez-Marrero (Malaga, ES)
08:30 Group 5.I M Graham (Dublin, IE)
08:30P302Perceived control and cardiovascular disease risk factors in PolandM Kozela (Krakow, PL)
08:30P303Depression, anxiety and psychological distress assessment a year after coronary artery bypass graftingO Raih (Kemerovo, RU)
08:30P304Impact of type D personality on life quality of patients with myocardial infarction and stroke or transient ischemic attackO Raih (Kemerovo, RU)
08:30P305Baseline MacNew Health Related Quality of Life drives outcome after PCIO Friedrich (Vienna, AT)
08:30P306Anxiety, depression and Health Related Quality of Life after PCI: gender specific differences in 2 European data samplesO Friedrich (Vienna, AT)
08:30P307Subjective well-being and its relation to physical activity in Swedish active seniorsLA Olsson (Orebro, SE)
08:30P308Health-related behaviors and diet quality of Polish women in procreative age in the context of the cardiovascular riskA Waskiewicz (Warsaw, PL)
08:30P309The long-term benefits of a community based vascular disease prevention programme on psychosocial outcomes - the West of Ireland experience.A Walsh (County Galway, IE)
08:30P310A nurse coordinated prevention programme improves quality of life in coronary patients: results from the RESPONSE trialM Minneboo (Amsterdam, NL)
08:30P311Anhedonia, but not other depressive or anxiety symptoms, predicts 8-year mortality in persons with acute coronary syndromeF Doyle (Dublin, IE)
08:30 Group 6.D Gaita (Timisoara, RO)
08:30P312Risk factors associated with acute coronary syndromes in south african asian indian patients the air studyN Ranjith (Durban, ZA)
08:30P313Decrease of bone mineral density as a marker of cardiovascular remodellingKurbasov Kurbasova Yulia (Smolensk, RU)
08:30P314Incidence of contrast induced nephropathy after angiogram compared to different radiological investigationsA Khan (Cork, IE)
08:30P315Clopidogrel and Proton Pump Inhibitors: preventing a potentially dangerous combination.V Vassiliou (Cambridge, GB)
08:30P316Predictors of new-onset of chronic kidney disease in Japanese population: Kyoto surveillanceS Yasuno (Kyoto, JP)
08:30P317Metabolic syndrome increases cardiomyocytes stress in human heart after cardiopulmonary bypassD Assanelli (Brescia, IT)
08:30P318Preventing cardiovascular complications after non-cardiac non-vascular surgery by using perioperative statin therapy. 1-year prospective study in Constanta County, RomaniaI R Parepa (Constanta, RO)
08:30P319Prognostic values of elevated Interleukin-6 and C - reactive protein for all-cause mortality in the elderly.A D Deev (Moscow, RU)
08:30P320High calcium score is a risk factor for clinical outcome despite normal myocardial perfusion and left ventricular ejection fraction as determined by 99mTc-sestamibi myocardial perfusion imagingB Zerahn (Herlev, DK)
08:30P321Association of subcutaneous allergen immunotherapy with incidence of autoimmune disease, ischaemic heart disease, and mortality: a nation-wide pharmaco-epidemiologic studyA Linneberg (Glostrup, DK)
08:30 Group 7.H Itoh (Tokyo, JP)
08:30P322Gender difference in factors associated to the Liver Steatosis Index in a large population sample: data from the Brisighella Heart StudyC Borghi (Bologna, IT)
08:30P323Vitamin d status and incidence of cardiovascular disease and mortality T Skaaby (Glostrup, DK)
08:30P324Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general populationT Skaaby (Glostrup, DK)
08:30P325Impact of a national media campaign on population knowledge and intentions in relation to stroke.A Hickey (Dublin 2, IE)
08:30P326Cardiovascular multimorbidity in primary care: the Clarity study.A W Murphy (Galway, IE)
08:30P327Impact of gender on the prognosis of elderly patients admitted for non-st-segment elevation acute coronary syndromeM A Ramirez-Marrero (Malaga, ES)
08:30P328Prognostic repercussion of advanced renal failure in patients admitted for non-st segment elevation acute coronary syndrome M A Ramirez-Marrero (Malaga, ES)
08:30P329The influence of partial and radical nephrectomy on cardiovascular risk factorsM Rostek (Warsaw, PL)
08:30P330Relative coronary risk in young individuals I Osipova (Barnaul, RU)
08:30P331Resting heart rate: a cardiovascular risk predictor for healthy middle aged menM Hellstrom (Oskarshamn, SE)
08:30 Group 8.T Joergensen (Glostrup, DK)
08:30P332The relationship between alcohol intake and selected cardiovascular risk factors in Polish men 
08:30P333Knowledge of risk factors for cardiovascular diseases in development of healthy lifestyle habits among third-year students at Wroclaw medical universityZA Domagala (Wroclaw, PL)
08:30P334Relation between high sensitivity C-reactive protein and intima media thickness in middle aged men and women K Szafraniec (Krakow, PL)
08:30P335Alcohol consumption patterns in a cohort of patients attending a community based cardiovascular disease prevention programmeG Flaherty (Co, Galway, IE)
08:30P336Can a novel community screening and brief intervention initiative achieve lifestyle changes and cardiovascular risk factor reductions in a high-risk population who do not attend general practice? A Houlihan (Co Mayo, IE)
08:30P337Mortality in male and female joggers 
08:30P338Conventional cardiovascular risk factors and their prognostic role in a cohort of post-menopausal women. The long-term follow-up of the "Bene Essere Donna" patientsY Bartolacelli (Sassuolo, IT)
08:30P339Chronic kidney disease in IrelandG Browne (Cork 1, IE)
08:30P340Association between nitrogen oxide synthase (NOS) single-nucleotide polymorphisms and coronary heart disease and hypertension in the INTERGENE studyA Levinsson (Gothenburg, SE)
08:30 Group 9.U Landmesser (Zurich, CH)
08:30P341Clinical characteristics and course of patients entering cardiac rehabilitation with chronic kidney disease: data from the Italian Survey on Cardiac Rehabilitation (ISYDE)F Giallauria (Naples, IT)
08:30 Compliance and predictors for physical activity after cardiac rehabilitation 
08:30P342Adaptation to intermittent hypoxia-hyperoxia as cardio-protective technology in patients with coronary artery diseaseO Glazachev (Moscow, RU)
08:30P343Increase in maximal oxygen uptake in the fight against inactivity?T Karlsen (Trondheim, NO)
08:30P344Risk factors in remote period after myocardial infarction: prevalence, control, prognostic value.A V Yagensky (Lutsk, UA)
08:30P345Do patients change their intention to attend cardiac rehabilitation and what factors influence any change? G McKee (Dublin, IE)
08:30P346Lower extremity functional electrical stimulation isometric contractions augment arm cycling peak oxygen uptake in spinal cord injured individualsB Brurok (Trondheim, NO)
08:30P347Impact of early physical exercise at rehabilitation stage on endothelial function in patients undergone coronary artery bypass grafting S Pomeshkina (Kemerovo, RU)
08:30P348Telephone support oriented by accelerometric measures enhances adherence to physical activity recommendations in non-compliant patients after a CRPT Guiraud (Toulouse, FR)
08:30P349Predictors of drop-out from cardiac rehabilitation programmes in EuropeW Benzer (Feldkirch, AT)
08:30P350Transient heart failure occurring in the acute and/or rehabilitative phase after coronary revascularization as a determinant of 1-year prognosis 
08:30 Group 10.M F Piepoli (Piacenza, IT)
08:30P351An Italian programme of secondary cardiovascular prevention and rehabilitation: medium-term effects on a real-life setting.M P Donataccio (Verona, IT)
08:30P352Analysis of reasons for refusal and drop-out of cardiac rehabilitation among the patients with ischaemic heart diseaseT Mikkelsen (Horsens, DK)
08:30P353Refusal of cardiac rehabilitation among patients with ischemic heart diseaseT Mikkelsen (Horsens, DK)
08:30P354Accelerometer as a tool to assess sedentarity and adherence to physical activity recommendations after CRPT Guiraud (Toulouse, FR)
08:30P355Is cardiac rehabilitation useful to old coronary patients?B Pavy (Machecoul, FR)
08:30P356Mapping the patient's experience: assessment of user needs, preferences and barriers for self management services in coronary artery diseaseN Peek (Amsterdam, NL)
08:30P357An intensive cardiovascular rehabilitation programme improves maximal oxygen uptake and quality of life in Danish patients with ischaemic heart diseaseJ Skov (Esbjerg, DK)
08:30P358Impact of diabetes on muscle mass, muscle strength, and exercise tolerance in elderly patients after coronary artery bypass graftingM Nishitani (Tokyo, JP)
08:30P359Beneficial effects of water exercise in cardiac rehabilitationM Deljanin Ilic (Niska Banja, RS)
08:30P360Role of Ranolazine in the rehabilitation of patients with ischemic heart disease after aorto-coronary bypass graftingG Caminiti (Rome, IT)
08:30 Group 11.O Ellingsen (Trondheim, NO)
08:30P361Adherent and Non-adherent Coronary Heart Disease Patients' Perceptions About Medicines and Healthcare ServicesR Khatib (Leeds, GB)
08:30P362Implementation of aerobic interval training in cardiac rehabilitation: a randomized clinical studyI-L Aamot (Heimdal, NO)
08:30P363Aims of a cardiac rehabilitation programme in young patients after acute coronary syndromeR Dalmau (Madrid, ES)
08:30P364Effects of a cardiac rehabilitation programme on diastolic filling properties and functional capacity in patients with myocardial infarction 
08:30P365Intensity of six-month cardio training in modification of vagal tone in patients with ischemic heart diseaseZA Domagala (Wroclaw, PL)
08:30P366The value of tele-rehabilitation in encouraging coronary artery disease patients to stay active after the acute rehabilitation phase.I N Frederix (Rotselaar, BE)
08:30P367Cardiac rehabilitation after acute coronary intervention: the patients viewP Johansson (Stockholm, SE)
08:30P368Changes in heart rate/work rate relationship and cardiorespiratory fitness following short-term rehabilitation in patients with cardiovascular disease L Ingle (Leeds, GB)
08:30 Group 12.E E Solberg (Oslo, NO)
08:30P369Exercise training vs. PCI - Ventilatory anaerobic threshold in patients with stable coronary artery diseaseS Hoppe (Leipzig, DE)
08:30P370Incidence of lone atrial fibrillation in men and women after long practice of the breath hold and/or SCUBA divingA Stuto (Siracusa, IT)
08:30P371Incidence of lone atrial fibrillation in men and women after long practice of the breath hold and/or scuba divingA Stuto (Siracusa, IT)
08:30P372Brugada ECG- pattern type 2 and 3 recorded with V1 and V2 in the third intercostal space is relatively common in young athletesA Menafoglio (Bellinzona, CH)
08:30P373Application of current esc recommendations for 12-lead resting ECG interpretation in professional football playersP Bohm (Saarbruecken, DE)
08:30P374The impact of gender and training volume on autonomic modulations in non-elite endurance athletes.M Wilhelm (Bern, CH)
08:30P375Prevalence of autonomic trigger mechanisms and athletic activity in patients undergoing ablative treatment for highly symptomatic atrial fibrillation 
08:30P376Pro-atrial natriuretic peptide and atrial remodelling in marathon and non-marathon runnersM Wilhelm (Bern, CH)
08:30 Group 13.A Mezzani (Veruno, IT)
08:30P377Exercise tests in liver transplantation candidatesR Glowczynska (Warsaw, PL)
08:30P378Metabolomic profile of human myocardial ischaemia assessed by nuclear magnetic resonance spectroscopy of peripheral blood serum. A translational study based on transient coronary occlusion models.C Bonanad Lozano (Valencia, ES)
08:30P379Duration of second window of cardioprotection of preconditioning with periodic acceleration (pGz)M Sackner (Miami, US)
08:30P380Prediction of exercise capacity by submaximal test in patients with coronary artery diseaseM P Tulppo (Oulu, FI)
08:30P381Respiratory compensation point and heart rate turning point precede the second lactate turning point in patients with chronic heart failureP J M Beckers (Edegem, BE)
08:30P382Comparison of carbohydrate and lipid oxidation during continuous and intermittent exercise in patients with chronic systolic heart failure.P Meyer (Geneva, CH)
08:30P383The role of extended electrical myostimulation in the treatment of chronic heart failureF van Buuren (Bad Oeynhausen, DE)